PTC Therapeutics, Inc. Payments to Acquire Productive Assets
PTC Therapeutics, Inc. (PTCT) reported Payments to Acquire Productive Assets of $20.25 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2019-10-30
- PTC Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2019-09-30 was $8.27M, a 111.86% increase year-over-year.
- PTC Therapeutics, Inc. payments to acquire productive assets for the quarter ending 2018-09-30 was $3.90M.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month |
|---|---|---|---|
| 2019-09-30 | $8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $20.25M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $11.98M 10-Q · filed 2019-08-06 | ||
| 2018-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $3.90M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | ||
| 2017-09-30 | $77.16M 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |